Bloomberg - Nov. 5 (Bloomberg) -- Takeda Pharmaceutical Co., Japan's largest drugmaker, forecast its biggest jump in annual profit in six years on sales of the best-selling Actos diabetes pill. Net income will rise 18 percent to 395 billion yen ($3.4 billion) in ...
